Orchestra BioMed Holdings's total assets for Q2 2024 were $72.38M, a decrease of -12.40% from the previous quarter. OBIO total liabilities were $28.26M for the fiscal quarter, a 11.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.